Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Catalyst4, Inc | Institution | 19 697 464 | 43,44% | US$ 546,60M | 2025-10-28 |
| Novo Holdings A/S | Institution | 3 686 622 | 8,13% | US$ 102,30M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 3 250 266 | 7,17% | US$ 90,19M | 2026-03-31 |
| Forbion Capital Partners B.V. | Institution | 3 226 400 | 7,12% | US$ 89,53M | 2026-03-31 |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | Institution | 3 226 400 | 7,12% | US$ 89,53M | 2025-12-31 |
| Pivotal BioVenture Partners LLC | Institution | 1 582 700 | 3,49% | US$ 43,92M | 2026-03-31 |
| BlackRock, Inc. | Institution | 1 339 731 | 2,95% | US$ 37,18M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1 133 385 | 2,50% | US$ 31,45M | 2026-03-31 |
| CHI Advisors LLC | Institution | 1 005 929 | 2,22% | US$ 27,91M | 2026-03-31 |
| 5AM Venture Management, LLC | Institution | 950 011 | 2,10% | US$ 26,36M | 2026-03-31 |
| Sanofi | Institution | 912 041 | 2,01% | US$ 25,31M | 2026-03-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 861 488 | 1,90% | US$ 23,91M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 719 820 | 1,59% | US$ 19,98M | 2026-03-31 |
| Velan Capital Partners LP | Institution | 492 893 | 1,09% | US$ 13,68M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 481 201 | 1,06% | US$ 13,35M | 2026-03-31 |
| Artal Group S.A. | Institution | 450 000 | 0,99% | US$ 12,49M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 420 000 | 0,93% | US$ 11,66M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 374 909 | 0,83% | US$ 10,40M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 364 705 | 0,80% | US$ 10,12M | 2026-03-31 |
| Mr. Vishwas Setia | Initiés | 356 256 | 0,79% | US$ 9,89M | 2026-05-06 |
| Dr. Erin Foff | Initiés | 346 059 | 0,76% | US$ 9,60M | 2026-05-07 |
| State Street Global Advisors, Inc. | Institution | 339 116 | 0,75% | US$ 9,41M | 2026-03-31 |
| Freestone Grove Partners LP | Institution | 313 957 | 0,69% | US$ 8,71M | 2026-03-31 |
| AXA Investment Managers S.A. | Institution | 267 746 | 0,59% | US$ 7,43M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 248 294 | 0,55% | US$ 6,89M | 2026-03-31 |
| Dr. James Lillie | Initiés | 242 729 | 0,54% | US$ 6,74M | 2026-05-07 |
| UBS Asset Management AG | Institution | 236 512 | 0,52% | US$ 6,56M | 2026-03-31 |
| Dr. Robert Malenka | Initiés | 216 893 | 0,48% | US$ 6,02M | 2026-04-27 |
| Dr. Anatol Kreitzer | Initiés | 211 190 | 0,47% | US$ 5,86M | 2026-04-27 |
| FMR LLC | Institution | 204 501 | 0,45% | US$ 5,67M | 2026-03-31 |
| Stanford Management Company | Institution | 199 231 | 0,44% | US$ 5,53M | 2026-03-31 |
| Superstring Capital Management LP | Institution | 192 139 | 0,42% | US$ 5,33M | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 171 006 | 0,38% | US$ 4,75M | 2026-03-31 |
| Mr. Kristopher Hanson | Initiés | 162 331 | 0,36% | US$ 4,50M | 2026-05-11 |
| Charles Schwab Investment Management, Inc. | Institution | 161 146 | 0,36% | US$ 4,47M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 146 172 | 0,32% | US$ 4,06M | 2026-03-31 |
| Lazard Asset Management LLC | Institution | 142 016 | 0,31% | US$ 3,94M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 131 231 | 0,29% | US$ 3,64M | 2026-03-31 |
| Dr. Christopher Kroeger | Initiés | 114 120 | 0,25% | US$ 3,17M | 2026-05-18 |
| Vanguard Portfolio Management, LLC | Institution | 112 604 | 0,25% | US$ 3,12M | 2026-03-31 |
| Tetragon Partners UK LLP | Institution | 112 115 | 0,25% | US$ 3,11M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.